Repeated administration of the novel antiepileptic agent levetiracetam does not alter digoxin pharmacokinetics and pharmacodynamics in healthy volunteers

Author： Levy R.H.   Ragueneau-Majlessi I.   Baltes E.  

Publisher： Elsevier

ISSN： 0920-1211

Source： Epilepsy Research, Vol.46, Iss.2, 2001-08, pp. : 93-99

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Levetiracetam does not alter body weight: analysis of randomized, controlled clinical trials

By Gidal B.E.   Sheth R.D.   Magnus L.   Herbeuval A.-F.  

Epilepsy Research, Vol. 56, Iss. 2, 2003-10 ,pp. : 121-126

Elsevier

Access to resources Recommend Favorite

Lack of effect of repeated administration of levetiracetam on the pharmacodynamic and pharmacokinetic profiles of warfarin

By Ragueneau-Majlessi I.   Levy R.H.   Meyerhoff C.  

Epilepsy Research, Vol. 47, Iss. 1, 2001-11 ,pp. : 55-63

Elsevier

Access to resources Recommend Favorite

Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trials

By Perucca E.   Gidal B.E.   Baltes E.  

Epilepsy Research, Vol. 53, Iss. 1, 2003-02 ,pp. : 47-56

Elsevier

Access to resources Recommend Favorite

Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy

By Gower A.J.   Hirsch E.   Boehrer A.   Noyer M.   Marescaux C.  

Epilepsy Research, Vol. 22, Iss. 3, 1995-11 ,pp. : 207-213

Elsevier

Access to resources Recommend Favorite

Blood and cerebrospinal fluid pharmacokinetics of the novel anticonvulsant levetiracetam (ucb L059) in the rat

By Doheny H.C.   Ratnaraj N.   Whittington M.A.   Jefferys J.G.R.   Patsalos P.N.  

Epilepsy Research, Vol. 34, Iss. 2, 1999-04 ,pp. : 161-168

Elsevier

Access to resources Recommend Favorite